B. Metzler Seel. Sohn & Co. Ag Moderna, Inc. Transaction History

B. Metzler Seel. Sohn & Co. Ag

$10 Billion
Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Moderna, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 22,673 shares of MRNA stock, worth $892,862. This represents 0.02% of its overall portfolio holdings.

Number of Shares

22,673

Previous 18,444 22.93%

Holding current value

$892,862

Previous $2.19 Million 30.82%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$63.64 - $125.14 $269,133 - $529,217	4,229 Added 22.93%	22,673 $1.52 Million
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $246,142 - $405,195	2,432 Added 15.19%	18,444 $2.19 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $141,116 - $190,822	1,653 Added 11.51%	16,012 $1.71 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $20,088 - $30,180	-289 Reduced 1.97%	14,359 $1.43 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $601,791 - $790,299	6,242 Added 74.26%	14,648 $1.51 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $76,551 - $103,702	646 Added 8.32%	8,406 $1.02 Million
Q1 2023 May 10, 2023	SELL	$135.66 - $197.02 $128,605 - $186,774	-948 Reduced 10.89%	7,760 $1.19 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $62,031 - $110,060	-524 Reduced 5.68%	8,708 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $82,412 - $135,537	698 Added 8.18%	9,232 $1.09 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $357,832 - $539,482	-3,055 Reduced 26.36%	8,534 $1.22 Million
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $37,938 - $70,515	-300 Reduced 2.52%	11,589 $2 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $2.68 Million - $4.38 Million	11,889 New	11,889 $2.99 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Account

B. Metzler Seel. Sohn & Co. Ag Moderna, Inc. Transaction History